Journal of Antimicrobial Chemotherapy, Vol 39, 273-276, Copyright © 1997 by The British Society for Antimicrobial Chemotherapy
MA Shapiro, JA Dever, JC Sesnie and SR VanderRoest
A cyclophosphamide-induced leucopenic mouse model was used to compare the
therapeutic efficacy of clinafloxacin, a fluoroquinolone in clinical
trials, with that of ciprofloxacin and imipenem/cilastatin, two clinically
relevant standard drugs. Acute systemic infections induced by Escherichia
coli, Pseudomonas aeruginosa, a penicillin- resistant Staphylococcus aureus
and a methicillin-resistant S. aureus (MRSA) were used to evaluate drug
efficacy. Median protective values (PD50) with 95% confidence limits were
determined in both leucopenic and normal mice. Results show that
clinafloxacin is potentially a useful agent in the treatment of neutropenic
patients.
JOURNAL ARTICLE
Comparative therapeutic efficacy of clinafloxacin in leucopenic mice
Department of Infectious Diseases, Parke-Davis Pharmaceutical Research, Ann Arbor, MI 48105, USA.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
L. M. Ednie, M. R. Jacobs, and P. C. Appelbaum Comparative Activities of Clinafloxacin against Gram-Positive and -Negative Bacteria Antimicrob. Agents Chemother., May 1, 1998; 42(5): 1269 - 1273. [Abstract] [Full Text] |
||||
